Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioMarin Pharmaceutical has announced that it has opened a new office in Brisbane, California, to expand its drug development operations and better meet the increasing demands of the company's growing product pipeline.
Subscribe to our email newsletter
The company will occupy approximately 20,000sqft of office space located north of the San Francisco International Airport at 2000 Sierra Point Parkway, adjacent to Highway 101. The facility will house staff in biostatistics, statistical programming, clinical data management, medical writing and other clinical development functions.
The new Brisbane office is part of a larger corporate expansion that has progressed throughout the past two years and includes the recent purchase of 300 Bel Marin Keys Boulevard in Novato, said BioMarin. The company has initiated targeted recruiting efforts for Brisbane-based positions.
Jean-Jacques Bienaime, BioMarin’s CEO, said: “BioMarin is making progress both domestically and internationally. With three drugs on the market and a rapidly growing product pipeline, we have accomplished a great deal in our short corporate history. We are very excited to further our expansion by opening new offices on the peninsula and adding much needed capacity to local operations in Novato.”